CryoPort (CYRX) Price & Analysis

Compare

641 Followers

CYRX Stock Chart & Stats

$9.21

$0.06(0.70%)

At close: Jan 08 4:00 PM EST

$9.21

$0.06(0.70%)

Day’s Range― - ―

52-Week Range$4.58 - $11.44

Previous CloseN/A

Volume42.91K

Average Volume (3M)690.07K

Market Cap

$489.17M

Enterprise Value$215.74M

Total Cash (Recent Filing)$421.31M

Total Debt (Recent Filing)$230.86M

Price to Earnings (P/E)―

Beta1.13

Next Earnings

Mar 11, 2026

EPS Estimate

-0.21

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.18

Shares Outstanding50,068,905

10 Day Avg. Volume860,552

30 Day Avg. Volume690,069

Financial Highlights & Ratios

PEG Ratio-0.03

Price to Book (P/B)0.94

Price to Sales (P/S)1.63

P/FCF Ratio-11.29

Enterprise Value/Market Cap0.44

Enterprise Value/Revenue1.13

Enterprise Value/Gross Profit2.43

Enterprise Value/Ebitda-15.30

Forecast

1Y Price Target

$13.63

Price Target Upside47.99% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering4

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Commercial GrowthCommercial revenue increased by an impressive 36% and contributed significantly to total revenue, highlighting the company's growth potential.

Market PotentialThe number of clinical trials being supported increased by 8%, indicating robust growth in cell and gene therapy approvals and filings.

Revenue PerformanceRevenue of $44.2M was well ahead of consensus estimates, driven by both Life Sciences Services and Life Sciences Products, signaling strong demand recovery.

Bears Say

CryoPort News

CryoPort Inc’s Earnings Call: Growth and Challenges

CryoPort Inc (($CYRX)) has held its Q3 earnings call. Read on for the main highlights of the call....

2M ago

CYRX

Cryoport price target raised to $12.50 from $11 at UBS

UBS raised the firm’s price target on Cryoport (CYRX) to $12.50 from $11 and keeps a Buy rating...

2M ago

CYRX

Positive Outlook for CryoPort Amid Strong Revenue Growth and Resurgent Demand

BTIG analyst David Larsen has maintained their bullish stance on CYRX stock, giving a Buy rating today. David...

2M ago

CYRX

CryoPort’s Strong Q3 Performance and Future Growth Potential Justify Buy Rating and Increased Price Target

Needham analyst David Saxon reiterated a Buy rating on CryoPort today and set a price target of $12.00....

2M ago

CYRX

Cryoport Reports Strong Q3 2025 Revenue Growth

CryoPort Inc ( ($CYRX) ) has released its Q3 earnings. Here is a breakdown of the information CryoPort...

2M ago

CYRX

Cryoport reports Q3 EPS (18c), consensus (19c)

Reports Q3 revenue $44.2M, consensus $41.22M. Jerrell Shelton, CEO of Cryoport (CYRX), commented, “Q3 was another outstanding quarter...

2M ago

CYRX

Cryoport raises FY25 revenue view to $170.0M-$174.0M from $165M-$172M

Consensus is for FY25 revenue $171.2M. Published first on TheFly – the ultimate source for real-time, market-moving breaking...

2M ago

CYRX

CYRX Upcoming Earnings Report: What to Expect?

CryoPort Inc (CYRX) is scheduled to report 3rd quarter earnings on 11/04/2025, after the market closes. Regarding Q3...

2M ago

CYRX

Cryoport launches state-of-the art facility in Louvres, France

Cryoport (CYRX) announced the launch of its newest, state-of-the art facility in Louvres, France, through its subsidiary, Cryoport...

3M ago

CYRX

Cryoport price target raised to $15 from $10 at BTIG

BTIG raised the firm’s price target on Cryoport (CYRX) to $15 from $10 and keeps a Buy rating...

3M ago

CYRX

CryoPort’s Promising Future: Buy Rating Backed by Strong Financials and Growing C&GT Market

Analyst David Larsen from BTIG maintained a Buy rating on CryoPort and increased the price target to $15.00...

3M ago

CYRX

CryoPort Delays 10-Q Filing Due to Compilation Challenges

CryoPort ( ($CYRX) ) has released a notification of late filing. CryoPort, Inc. has announced a delay in...

5M ago

CYRX

Cryoport Inc’s Earnings Call Highlights Growth and Optimism

CryoPort Inc (($CYRX)) has held its Q2 earnings call. Read on for the main highlights of the call....

5M ago

CYRX

CryoPort’s Strong Q2 2025 Performance and Growth Prospects Justify Buy Rating

In a report released today, David Saxon from Needham maintained a Buy rating on CryoPort, with a price...

5M ago

CYRX

CYRX FAQ

What was CryoPort Inc’s price range in the past 12 months?

CryoPort Inc lowest stock price was $4.58 and its highest was $11.44 in the past 12 months.

What is CryoPort Inc’s market cap?

CryoPort Inc’s market cap is $489.17M.

When is CryoPort Inc’s upcoming earnings report date?

CryoPort Inc’s upcoming earnings report date is Mar 11, 2026 which is in 75 days.

How were CryoPort Inc’s earnings last quarter?

CryoPort Inc released its earnings results on Nov 04, 2025. The company reported -$0.18 earnings per share for the quarter, beating the consensus estimate of -$0.223 by $0.043.

Is CryoPort Inc overvalued?

According to Wall Street analysts CryoPort Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does CryoPort Inc pay dividends?

CryoPort Inc does not currently pay dividends.

What is CryoPort Inc’s EPS estimate?

CryoPort Inc’s EPS estimate is -0.21.

How many shares outstanding does CryoPort Inc have?

CryoPort Inc has 50,068,905 shares outstanding.

What happened to CryoPort Inc’s price movement after its last earnings report?

CryoPort Inc reported an EPS of -$0.18 in its last earnings report, beating expectations of -$0.223. Following the earnings report the stock price went down -7.484%.

Which hedge fund is a major shareholder of CryoPort Inc?

Currently, no hedge funds are holding shares in CYRX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

CryoPort Stock Smart Score

Neutral

Fundamentals

Return on Equity

-9.96%

Trailing 12-Months

Asset Growth

-9.20%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

CryoPort Inc

CryoPort, Inc. is a logistics company specializing in temperature-controlled shipping solutions for the life sciences industry, particularly in the fields of biopharmaceuticals and regenerative medicine. The company provides a range of services including cryogenic storage, transportation, and related logistics support for sensitive biological materials. CryoPort's core products include its CryoPort Express® shipping solutions, CryoPort Express® systems, and associated monitoring technologies, which ensure the safe and reliable transport of critical biological samples and products.

CryoPort (CYRX) Earnings & Revenues

Historic Earnings Reports

CYRX Company Deck

CYRX Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call presented a mostly positive outlook with strong growth in key segments, strategic expansions, and increased clinical trial support. However, there are some concerns about sequential revenue guidance and external factors like the government shutdown impacting operations.View all CYRX earnings summaries

CYRX Stock 12 Month Forecast

Average Price Target

$13.63

▲(47.99% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","7":"$7","10":"$10","13":"$13","16":"$16"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.63,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$13.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,7,10,13,16],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.24,9.683076923076923,10.126153846153846,10.569230769230769,11.012307692307692,11.455384615384615,11.89846153846154,12.341538461538462,12.784615384615385,13.227692307692308,13.670769230769231,14.113846153846154,14.556923076923077,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.24,9.577692307692308,9.915384615384616,10.253076923076923,10.590769230769231,10.928461538461539,11.266153846153847,11.603846153846154,11.941538461538462,12.27923076923077,12.616923076923078,12.954615384615385,13.292307692307693,{"y":13.63,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.24,9.452307692307693,9.664615384615384,9.876923076923077,10.089230769230769,10.301538461538462,10.513846153846155,10.726153846153846,10.938461538461539,11.150769230769232,11.363076923076923,11.575384615384616,11.787692307692307,{"y":12,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.21,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.15,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.78,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.78,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.57,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.09,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.46,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.31,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.27,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.81,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.24,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >